CIK 0001604464 · Non-accelerated filer<br>Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460920988
- Phone
- 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 8-K Event Executive or director change
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Grant or award Director acquired 57,000 shares (grant or award)
- 4 Open-market sale EVP, Chief Legal Officer sold 8,389 shares at an average $2.04 ($17,089)
- 4 Open-market sale EVP, Chief Technical Officer sold 19,040 shares at $2.04 ($38,784)
- 4 Open-market sale President and CEO sold 29,766 shares at $2.04 ($60,633)
- 4 Open-market sale SVP, CFO sold 7,918 shares at an average $2.04 ($16,131)
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 3 Insider Initial Statement of Ownership
- DEFA14A Proxy Proxy Materials
Page 14 of 57 · 1,133 filings